Author
The purpose of the secondary patent filings was to assemble a thicket of patents, 132 in all, to prohibit competition from biosimilar companies.
Over a decade after being recalled, rofecoxib received orphan drug designation for the treatment of pain caused by hemophilic arthropathy.
By Gregory Curfman This new post by Gregory Curfman appears on the Health Affairs Blog in a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard Law School on Monday, January 23, 2017. With health care spending approaching…
By Gregory Curfman Just when the Affordable Care Act (ACA) has won a second major Supreme Court victory in King v. Burwell, conservative critics of the ACA are back on the attack, this time directing…
By Gregory Curfman Bill of Health contributor Gregory Curfman has a new piece up at the Health Affairs Blog discussing the Supreme Court’s decision in King v. Burwell in the broader context of Americans’ right to care. From the…
By Holly F. Lynch, I. Glenn Cohen, and Gregory Curfman This new post by Holly F. Lynch, I. Glenn Cohen, and Gregory Curfman appears on the Health Affairs Blog as the final entry in a series stemming from the Third Annual…
By Greg Curfman, Holly Fernandez Lynch and I. Glenn Cohen This new blog post by Greg Curfman, Holly Fernandez Lynch and I. Glenn Cohen appears on the Health Affairs Blog: Everywhere we look, we see the tremendous impact of…
By Greg Curfman and Holly Fernandez Lynch It was as if lightning had struck twice in the same place. On Tuesday two pivotal federal circuit court opinions that could dramatically impact the future of Obamacare…
By Gregory Curfman Tom Goldstein, Publisher of SCOTUSblog, has opined on why Justice Stephen Breyer apparently joined the majority opinion in Wheaton College v. Burwell, which the Court released last Thursday. The majority granted Wheaton…
By Gregory Curfman and Holly Fernandez Lynch [A quick follow up to our recent NEJM Perspective on the case, with I. Glenn Cohen] Immediately after Justice Samuel Alito’s announcement on June 30 of the majority opinion…
